Back to search

Peptide record

TPDB40618

14VL23 Anticancer standard
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB40618
14VL23
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 22-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
ALWKSILKNAGKAVLNEINQIV-NH2
Physicochemical Analysis
C111H188N30O30
RDCHMFPTY
ANILK
2422.90
10.32
3
1
12
+2
2.14
0.336
146.36
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
5500
227.00
5
Residue Composition
number
3
A
0
R
3
N
0
D
0
C
1
E
1
Q
1
G
0
H
3
I
3
L
3
K
0
M
0
F
0
P
1
S
0
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 3 R: 0 N: 3 D: 0 C: 0 E: 1 Q: 1 G: 1 H: 0 I: 3 L: 3 K: 3 M: 0 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 2
Chemical Descriptors
22
C111H188N30O30
2422.90
10.32
+2
2.14
0.336
Amidation
L
Linear
Free
Antimicrobial and Anticancer
Dermaseptin-SS1- Analog
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 5.7 µM
Anticancer
5.7 µM

Target

Lung Cancer
H-838
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 16.4 µM
Anticancer
16.4 µM

Target

Lung Cancer
H-460
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023